For other uses, see Deathlok (disambiguation) |
- "Are you proposing to sell us this super soldier of yours?"
"God, no! I’m proposing to sell you a thousand of them, better, stronger, faster. Gentleman, with the continued exposure of corrupt institutions like S.H.I.E.L.D., with the terrifying rise of HYDRA, the need for reliable security is at an all-time high. Which is why we are expanding our super soldier operations into a brand new, state of the art Cybertek facility. So would you and your friends like a tour?" - ―Jacobs and Ian Quinn[src]
The Deathlok Soldiers were a group of Super Soldiers that were a product of Project Deathlok, who relied on cybernetic prosthetics created by the Cybertek Corporation to maintain normal function after being severely injured in battle. After Cybertek began working closely with the Centipede Project, the two groups merged their resources and planned to create Deathlok Soldiers enhanced by the Centipede Serum, Cybertek Prosthetics, and GH.325. Only one of these soldiers was actually created: John Garrett.
History
John Garrett sent Deathlok to Colombia to kill drug lord Alejandro Castillo in a spectacular way so that those who saw the news would be impressed with Deathlok and his capabilities.
In Washington, D.C., Ian Quinn spoke with General Jacobs and Admiral Jolnes about selling a thousand Deathlok Soldiers to the US government in a highest bidder.[1]
During S.H.I.E.L.D.'s assault on the Cybertek facility where the Deathlok Soldiers were to be produced, Coulson's Team, with the aid of United States Marines, were able to confiscate the facility and the machines before mass-production could begin. However, John Garrett eluded custody long enough to use the prototype machine on himself to become a super soldier before being destroyed by Phil Coulson.[2]
Trivia
- After Melinda May and Phil Coulson infiltrated a Cybertek facility, it is revealed that files pertaining to Project Deathlok go as far back as 1990, the same year as the debut of the first Deathlok solo comic book series.